Following a turbulent year for the markets in general and biotech in particular, the industry made a notable recovery, ...

Corcept Therapeutics Inc. (NASDAQ: CORT) is one of the 10 best biotech stocks with highest upside potential.

In 2025, biotechnology stocks had their best year since the COVID-19 pandemic, with the market sector’s two major indexes — the SDPR S&P Biotech ETX (NYSE: XBI) and iShares Biotech ETF (NYSE: IBB) — ...

State Street SPDR S&P Biotech ETF (XBI) gained +40.32% over the past year and equally weights roughly 145 stocks to provide exposure to smaller biotech companies. iShares Biotechnology ETF (IBB) ...

After a four-year downturn, early signs in 2026 suggest biotech funding is stabilizing. Danaher is guiding for 3%–6% revenue ...

This company has more than one iron in the fire. The post This ASX biotech stock could more than double Canaccord Genuity says appeared first on The Motley Fool Australia.

Mesoblast hits a key trial milestone... The post A big milestone for this ASX biotech. Here's why the share price is moving appeared first on The Motley Fool Australia.

Biotech stocks saw a major rebound in 2025, with key indexes significantly outperforming the S&P 500. Private investment in longevity science doubled in 2024, highlighting growing interest in ...